NasdaqGM:HROWPharmaceuticals
Should Harrow’s (HROW) CCO Promotion and Reaffirmed 2025 Revenue Guidance Require Action From Investors?
Harrow, Inc. recently promoted Patrick W. Sullivan, age 50, to Chief Commercial Officer effective January 30, 2026, and reaffirmed its full-year 2025 revenue guidance of US$270 million to US$280 million.
By elevating an experienced commercial leader with a track record across major pharmaceutical launches while reiterating revenue expectations, Harrow is signaling both commercial focus and operational steadiness.
Next, we’ll consider how Sullivan’s promotion to Chief Commercial Officer might...